Nomination Committee of Medivir appointed
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the nomination committee now has been appointed ahead of the Annual General Meeting in May 2024.According to an AGM resolution, the Nomination Committee 2023-2024 should consist of representatives of at least the three largest shareholders at the end of the third quarter of 2023 and the Chairman of the Board. Work on composing the Nomination Committee is now completed, and this year’s Nomination Committee consists of: Karl Tobieson, appointed by Linc ABRichard Torgerson, appointed by Nordea Investment